NewGenIvf Group Limited announced a reverse stock split of all issued and unissued shares at a ratio of one for three. The transaction reduces outstanding Class A Ordinary Shares from 10,259,764 to approximately 3,419,922. The split becomes effective at 12:01 a.m. ET on July 6, 2026, with shares trading on the Nasdaq Capital Market on a split-adjusted basis under the symbol NIVF and a new CUSIP G0544E501. Options, warrants, and convertible securities will be adjusted accordingly, and fractional shares will be rounded up to the nearest full share. The company operates in the healthcare industry, providing fertility services.
